New Study Warns Removing Universal Hepatitis B Birth-Dose Vaccinations Would Increase Neonatal Infections in the US

A JAMA Pediatrics study warns that removing universal Hep B birth-dose vaccines would increase neonatal infections due to gaps in maternal screening.

By: AXL Media

Published: Apr 28, 2026, 6:04 AM EDT

Source: Information for this report was sourced from EurekAlert

The Potential Risks of Transitioning to Targeted Immunization

A new statistical estimation published in JAMA Pediatrics has raised significant concerns regarding the stability of neonatal health if universal Hepatitis B virus (HBV) vaccination protocols are altered. The study analyzed the projected impact of replacing the current universal birth-dose mandate with a targeted recommendation system. Researchers found that such a shift would almost certainly lead to an increase in both immediate neonatal infections and subsequent long-term chronic HBV cases across the United States. According to lead author Margaret L. Lind, the findings suggest that the universal birth dose remains a critical defense against the transmission of the virus from mother to child.

Maternal Screening Failures and the Safety Net of Universal Care

The study highlights a critical vulnerability in the targeted vaccination model: its absolute dependence on the accuracy and reach of maternal screening. For a targeted approach to work, every pregnant woman would need to be screened for HBV to ensure that infants born to infected mothers receive the vaccine immediately. However, the research indicates that unless maternal screening rises substantially beyond current historical levels, many infants will inevitably fall through the cracks. The universal birth-dose policy currently acts as a fail-safe, ensuring protection even when a mother's status is unknown or a screening result is missing at the time of delivery.

Statistical Realities of Vaccination Coverage for Unscreened Mothers

Data analysis from the study suggests that the success of a targeted program would also require vaccination coverage among infants of unscreened mothers to exceed current national levels. Based on historical immunization trends, the researchers argue that such a significant improvement in coverage is unlikely to occur spontaneously. Without the universal requirement, the burden of identifying at-risk infants shifts entirely to clinical screening processes that have historically proven imperfect. The study maintains that relying on a targeted approach without first achieving near-perfect screening rates would create a dangerous gap in public health defenses.